文献速递免疫规划传染病防控与疫情报告

上海市不同毒株脊髓灰质炎疫苗序贯接种的免疫原性分析

[Immunogenicity analysis of sequential inoculation of different strains of poliomyelitis vaccines in Shanghai].
PubMed 文献 · Zhonghua Yu Fang Yi Xue Za Zhi · 2019-01-01

该平行对照试验于2016年3月至2017年9月在上海市预防接种门诊纳入325名2月龄婴儿,比较四种sIPV、wIPV与bOPV序贯程序的免疫原性。完成基础免疫前后采血的151名婴儿中,脊灰Ⅰ型中和抗体阳转率为98.68%,Ⅲ型为97.35%,各组间差异无统计学意义(P=0.345、P=0.614)。结论认为同时或交替使用sIPV和wIPV的序贯程序对适龄婴儿均具有良好的免疫原性。

要点

  • sIPV与wIPV同时或交替序贯免疫对适龄婴儿均具良好免疫原性。
  • 基础免疫后脊灰Ⅰ型中和抗体阳转率为98.68%。
  • 基础免疫后脊灰Ⅲ型中和抗体阳转率为97.35%。

核心结论

  • 同时或交替使用sIPV和wIPV开展脊髓灰质炎疫苗序贯免疫程序对于适龄婴儿均具有良好的免疫原性。

研究设计与样本

  • 采用平行对照设计,于2016年3月至2017年9月在上海市预防接种门诊招募符合纳入排除标准的受种者为研究对象。
  • 以sIPV、wIPV和bOPV作为研究疫苗,按4种序贯免疫程序分组:sIPV+sIPV+bOPV、sIPV+wIPV+bOPV、wIPV+sIPV+bOPV和wIPV+wIPV+bOPV。
  • 325名婴儿在2、3、4月龄接种,基础免疫前采血230份、基础免疫后采血163份,完成基础免疫前后采血者共151名,每组分别为36、44、30和41名。

主要发现

  • 151名研究对象月龄为(2.27±0.61)个月,出生体重为(3.27±0.43)kg,其中男性70名。
  • 脊灰Ⅰ型中和抗体阳转率为98.68%(149例),Ⅲ型为97.35%(147例)。
  • 各组免疫后Ⅰ型阳转率分别为97.22%(35例)、100.00%(44例)、96.67%(29例)和100.00%(41例)(P=0.345)。
  • 各组免疫后Ⅲ型阳转率分别为97.22%(35例)、95.45%(42例)、96.67%(29例)和100.00%(41例)(P=0.614)。

临床怎么用

  • 对于适龄婴儿,可考虑同时或交替使用sIPV和wIPV开展脊髓灰质炎疫苗序贯免疫程序。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the immunogenicity of different strains of inactivated poliomyelitis vaccines (IPV) by sequential program. Methods: This parallel-group controlled trial was conducted in immunization clinics in Shanghai from March 2016 to September 2017. Sabin strains inactivated poliomyelitis vaccines (sIPV), WPV strains inactivated poliomyelitis vaccines (wIPV) and live poliomyelitis Type Ⅰ Type Ⅲ vaccine (bOPV) as the investigational vaccine were used at 2, 3, 4 months old in 325 infants in Shanghai. Infants vaccinated by four sequential program were divided into 4 groups: sIPV+sIPV+bOPV, sIPV+wIPV+bOPV, wIPV+sIPV+bOPV and wIPV+wIPV+bOPV. A total of 230 investigators' blood samples were collected before primary immunization and 163 investigators' blood samples were collected after primary immunization. A total of 151 investigators (36, 44, 30 and 41 in each group) finished primary immunization and blood sampling before and after the primary immunization. The geometric mean titer (GMT) of poliovirus typesⅠ and Ⅲ neutralizing antibody was tested and calculated, and the positive results of antibody before and after primary immunization were analyzed. Results: Among the 151 investigators, the age were (2.27±0.61) months and birth weight were (3.27±0.43) kg, and 70 were male. The positive rates of typeⅠwas 98.68% (149 cases), and type Ⅲ was 97.35% (147 cases); the number of investigators tested in each group was 36, 44, 30 and 41, respectively; the positive rates of typeⅠwas 97.22% (35 cases), 100.00% (44 cases), 96.67% (29 cases) and 100.00% (41 cases) (P=0.345); the positive rates of type Ⅲ were 97.22% (35 cases), 95.45% (42 cases), 96.67% (29 cases) and 100.00% (41 cases) (P=0.614). Conclusion: Using sIPV and wIPV simultaneously or alternately for sequential immunization of poliomyelitis vaccines showed good immunogenicity for infants at appropriate age. 目的: 评价不同毒株脊髓灰质炎(脊灰)疫苗序贯免疫程序的免疫原性。 方法: 采用平行对照设计,于2016年3月至2017年9月,在上海市招募各区符合纳入排除标准的预防接种门诊受种者为研究对象,以Sabin株脊灰灭活疫苗(sIPV)、野毒株脊灰灭活疫苗(wIPV)和Ⅰ+Ⅲ型脊灰减毒活疫苗(bOPV)作为研究疫苗,按照4种序贯免疫程序进行基础免疫并分组,即接种sIPV+sIPV+bOPV、sIPV+wIPV+bOPV、wIPV+sIPV+bOPV和wIPV+wIPV+bOPV组,完成基础免疫前采血、基础免疫并采血者共151名,每组分别为36、44、30和41名;检测并计算脊灰Ⅰ、Ⅲ型中和抗体几何平均滴度(GMT)对数转换值,分析研究对象基础免疫后抗体阳性及阳转情况。 结果: 151名研究对象的月龄为(2.27±0.61)个月,出生体重为(3.27±0.43)kg,其中男性为70名。脊灰Ⅰ型中和抗体阳转率为98.68%(149例),Ⅲ型为97.35%(147例);各组分别检测了36、44、30和41名,免疫后Ⅰ型阳转率分别为97.22%(35例)、100.00%(44例)、96.67%(29例)和100.00%(41例)(P=0.345),Ⅲ型分别为97.22%(35例)、95.45%(42例)、96.67%(29例)和100.00%(41例)(P=0.614)。 结论: 同时或交替使用sIPV和wIPV开展脊髓灰质炎疫苗序贯免疫程序对于适龄婴儿均具有良好的免疫原性。.

来源:Zhonghua Yu Fang Yi Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Huang ZY, Sun XD, Liu MY, et al. [Immunogenicity analysis of sequential inoculation of different strains of poliomyelitis vaccines in Shanghai]. Zhonghua Yu Fang Yi Xue Za Zhi. 2019. PMID: 31091611. doi:10.3760/cma.j.issn.0253-9624.2019.05.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。